Novavax, Inc. (NVAX)
7.955
0.00 (0.00%)
USD |
NASDAQ |
Nov 18, 16:00
8.00
+0.04
(+0.57%)
After-Hours: 20:00
Novavax 30-Day Average Daily Volume : 6.973M for Nov. 17, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 17, 2026 | 6.973M |
| November 16, 2026 | 7.502M |
| November 13, 2026 | 8.301M |
| November 12, 2026 | 8.280M |
| November 11, 2026 | 8.151M |
| November 10, 2026 | 8.107M |
| November 09, 2026 | 7.834M |
| November 06, 2026 | 7.699M |
| November 05, 2026 | 7.620M |
| November 04, 2026 | 7.491M |
| November 03, 2026 | 7.483M |
| November 02, 2026 | 7.620M |
| October 30, 2026 | 7.688M |
| October 29, 2026 | 7.924M |
| October 28, 2026 | 8.127M |
| October 27, 2026 | 8.063M |
| October 26, 2026 | 7.949M |
| October 23, 2026 | 7.896M |
| October 22, 2026 | 7.953M |
| October 21, 2026 | 7.741M |
| October 20, 2026 | 7.708M |
| October 19, 2026 | 7.631M |
| October 16, 2026 | 7.595M |
| October 15, 2026 | 7.473M |
| October 14, 2026 | 7.415M |
| Date | Value |
|---|---|
| October 13, 2026 | 7.465M |
| October 12, 2026 | 7.428M |
| October 09, 2026 | 7.284M |
| October 08, 2026 | 6.764M |
| October 07, 2026 | 6.674M |
| October 06, 2026 | 6.632M |
| October 05, 2026 | 6.171M |
| October 02, 2026 | 5.562M |
| October 01, 2026 | 5.627M |
| September 30, 2026 | 5.904M |
| September 29, 2026 | 5.819M |
| September 28, 2026 | 5.748M |
| September 25, 2026 | 5.675M |
| September 24, 2026 | 5.662M |
| September 23, 2026 | 5.601M |
| September 22, 2026 | 5.496M |
| September 21, 2026 | 5.350M |
| September 18, 2026 | 5.336M |
| September 17, 2026 | 5.128M |
| September 16, 2026 | 4.953M |
| September 15, 2026 | 4.967M |
| September 14, 2026 | 4.942M |
| September 11, 2026 | 4.943M |
| September 10, 2026 | 4.836M |
| September 09, 2026 | 4.717M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 15.83M |
| Merck & Co., Inc. | 9.475M |
| Pfizer Inc. | 34.17M |
| Amgen, Inc. | 2.647M |
| Editas Medicine, Inc. | 2.386M |